Celcuity, Inc. (CELC)
92.27
+1.48
(+1.63%)
USD |
NASDAQ |
Aug 25, 16:00
91.50
-0.77
(-0.83%)
After-Hours: 07:13
Celcuity Total Assets (Quarterly) : 828.22M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 828.22M |
| March 31, 2026 | 410.16M |
| December 31, 2025 | 466.56M |
| September 30, 2025 | 476.00M |
| June 30, 2025 | 183.59M |
| March 31, 2025 | 218.13M |
| December 31, 2024 | 245.12M |
| September 30, 2024 | 273.04M |
| June 30, 2024 | 292.54M |
| March 31, 2024 | 188.18M |
| December 31, 2023 | 191.22M |
| September 30, 2023 | 142.38M |
| June 30, 2023 | 153.52M |
| March 31, 2023 | 164.88M |
| December 31, 2022 | 175.70M |
| September 30, 2022 | 65.29M |
| June 30, 2022 | 72.35M |
| March 31, 2022 | 79.93M |
| December 31, 2021 | 85.91M |
| Date | Value |
|---|---|
| September 30, 2021 | 91.84M |
| June 30, 2021 | 42.81M |
| March 31, 2021 | 36.37M |
| December 31, 2020 | 12.96M |
| September 30, 2020 | 14.91M |
| June 30, 2020 | 16.70M |
| March 31, 2020 | 18.39M |
| December 31, 2019 | 20.28M |
| September 30, 2019 | 21.74M |
| June 30, 2019 | 23.44M |
| March 31, 2019 | 24.94M |
| December 31, 2018 | 26.03M |
| September 30, 2018 | 27.89M |
| June 30, 2018 | 29.47M |
| March 31, 2018 | 30.73M |
| December 31, 2017 | 31.97M |
| September 30, 2017 | 33.15M |
| June 30, 2017 | 11.69M |
| March 31, 2017 | 5.090M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 834.55M |
| Replimune Group, Inc. | 252.45M |
| Erasca, Inc. | 435.05M |
| Apogee Therapeutics, Inc. | 1.336B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 841.00M |
| Shareholders Equity (Quarterly) | -12.78M |
| Debt to Equity Ratio | -59.02 |
| Current Ratio | 8.931 |
| Net Debt Paydown Yield | -2.56% |